Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
559 hedge funds and large institutions have $11.4B invested in Abiomed Inc in 2019 Q1 according to their latest regulatory filings, with 88 funds opening new positions, 213 increasing their positions, 188 reducing their positions, and 53 closing their positions.
66% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 53
13% more repeat investments, than reductions
Existing positions increased: 213 | Existing positions reduced: 188
6% more funds holding
Funds holding: 529 → 559 (+30)
11% less capital invested
Capital invested by funds: $12.8B → $11.4B (-$1.45B)
45% less call options, than puts
Call options by funds: $165M | Put options by funds: $300M
54% less funds holding in top 10
Funds holding in top 10: 13 → 6 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$163M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$149M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$85.4M |
| 4 |
Renaissance Technologies
New York
|
+$63.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$58.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$170M |
| 2 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$106M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$73.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$63M |
| 5 |
FAM
Fred Alger Management
New York
|
-$52.8M |
ABMD Hedge Fund Activity: Q1 2019 in Review
559 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2019, worth a combined $11.4B — down 11% from $12.8B a quarter earlier.
Buyers outnumbered sellers: 88 funds opened new ABMD positions and 53 closed out — a net gain of 35 holders — while 213 added to existing stakes and 188 trimmed.
The largest buyer was Amundi Asset Management US, adding an estimated $163M. The largest seller was Winslow Capital Management, exiting entirely with an estimated $170M sold.
- 559 institutional investors held Abiomed Inc (ABMD) as of Q1 2019, up from 529 in Q4 2018.
- Funds reported $11.4B of Abiomed Inc stock for Q1 2019, down 11% quarter-over-quarter.
- 88 funds opened new Abiomed Inc positions in Q1 2019 and 53 closed out, a net change of +35 holders.
- The largest Abiomed Inc buyer in Q1 2019 was Amundi Asset Management US, an estimated $163M added.
- The largest Abiomed Inc seller in Q1 2019 was Winslow Capital Management, an estimated $170M sold.
Based on aggregated 13F filings for Q1 2019.